NS.MEDIC
The computed 12-month bankruptcy probability of NS.MEDIC is 0.2% (very low). The 2024 annual accounts show equity of €285k and a net result of €184k. Its solvency ranks better than 95% of 6554 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €285k |
| Net result | €184k |
| Better than sector | 95% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 97.7% | 66.7% | |
| Net result | €184k | €46k | |
| Equity | €285k | €79k | |
| Gross operating margin | €254k | €78k | |
| Total assets | €292k | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €253k |
| Net profit | €184k |
| Cash flow | €191k |
| Staff costs | - |
| Income taxes | €62k |
| Dividends | - |
| Total assets | €292k |
| Equity | €285k |
| Debt | €7k |
| of which ≤ 1y | €7k |
| of which > 1y | - |
| Working capital | €273k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 40.92 |
| Quick ratio | 40.92 |
| Working capital ratio | 93.6% |
| Solvency | 97.7% |
| Debt / equity | 0.02 |
| Long-term debt ratio | - |
| Interest coverage | 2937.95 |
| Gross margin | - |
| Net margin | - |
| ROA | 63.1% |
| ROE | 64.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €292k |
| Fixed assets | 21/28 | €12k |
| Tangible fixed assets | 22/27 | €12k |
| Current assets | 29/58 | €280k |
| Amounts receivable within one year | 40/41 | €3k |
| Investments | 50/53 | €80k |
| Cash & bank | 54/58 | €171k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €292k |
| Equity | 10/15 | €285k |
| Contributions / capital | 10/11 | €2k |
| Accumulated profits (losses) | 14 | €283k |
| Amounts payable | 17/49 | €7k |
| Amounts payable within one year | 42/48 | €7k |
| Trade debts payable within one year | 44 | €293 |
| Income statement | ||
| Gross operating margin | 9900 | €254k |
| Operating result | 9901 | €246k |
| Financial charges | 65 | €86 |
| Result before taxes | 9903 | €246k |
| Income taxes | 67/77 | €62k |
| Net result for the period | 9904 | €184k |
| Result to be appropriated | 9905 | €184k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 07-03-2023 |
| Status | Active |
| Postal code | 1410 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21016B0025/00X003 | Brussels | 427 m² | 1 · 210 m² | 21.0 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-08-2025 Registered office moved from Uccle to Waterloо
- Rue du Postillon 30 à 1180 Uccle → Avenue Sir Walter Scott 17 à 1410 Waterloо
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Avenue Sir Walter Scott 17 \u00E0 1410 Waterlo\u043E",
"city": "Waterlo\u043E",
"region": "waals_gewest",
"street": "Avenue Sir Walter Scott",
"country": "BE",
"postcode": "1410",
"box_number": null,
"street_number": "17",
"locality_suffix": null
},
"old_address": {
"raw": "Rue du Postillon 30 \u00E0 1180 Uccle",
"city": "Uccle",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Rue du Postillon",
"country": "BE",
"postcode": "1180",
"box_number": null,
"street_number": "30",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-08-19",
"filing_date": "2025-08-11",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2025-06-17",
"unanimous": true
},
"subject_company": {
"kbo": "0799.234.072",
"name_full": "NS.MEDIC",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "SELVAIS Nicolas",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | NS.MEDIC |